Clinical Trial Update: A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of TTP054 in Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TTP054

Snippet

Sponsor: vTv Therapeutics | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED